The Power of Pills: Social, Ethical and Legal Issues in Drug Development, Marketing and Pricing
Besorgung - Lieferbarkeit unbestimmt
BeschreibungUnique textbook covering everything you need to know about the pharmaceutical industry -- from regulation to ethical questions
InhaltsverzeichnisChapter 1: Pharmaceutical Industry, Profits and Obligations 1. The Pharmaceutical Industry and the Pursuit of Profits by Joel Lexchin 2. Social, Ethical and Legal Issues in Drug Development, Marketing and Pricing Policies: 'Setting Priorities: Pharmaceuticals as Private Organizations and the Duty to Make Money/Maximize Profits' by Kristina M. Lybecker 3. The Pharmaceutical Industry and its Obligations in the Developing World by Ann Mills, Patricia Werhane, and Michael Gorman 4. Drug Companies as Organizational Hybrids by Warren Kaplan 5. Physicians and the Pharmaceutical Industry: A Symbiotic Relationship? by Ian E Marshall 6. Industry Perspectives on Equity, Access and Corporate Social Responsibility: A View from the Inside by Robert A Freeman Chapter 2: Justice - Medicines as Global Public Goods 1. Pharmaceuticals, Public Health and the Law: A Public Health Perspective by W.E. Parmet 2. Access to Medications and Global Justice by David. Resnik 3. Pharmacogenetics and Global (In)Justice by Soren Holm Chapter 3: The Social, Ethical and Political Challenge: Neglected Diseases 1. The Enduring Crisis in Neglected Diseases by Nathan Ford 2. Moving Beyond Charity for R&D for Neglected Diseases by J. Orbinski and B. Burciul 3. Neglected Disease Research: Health Needs and New Models for R&D by Aidan Hollis 4. Advance Purchase Commitments: Moral and Practical Problems by Donald W. Light 5. Harnessing the Power of Pharmaceutical Innovation by Thomas Pogge Chapter 4: Patents and Access to Medicines 1. Patents, Profits, and the Price of Pills: Implications for Access and Availability by Michael J Selgelid and Eline M. Sepers 2. Fair Followers Expanding Access to Generic Pharmaceuticals for Low-Income Populations by Kevin Outterson 3. Abolishing the Product Patent: A Step Forward for Global Access to Drugs by Adam Mannan and Alan Story 4. Trading Health for Profit: Bilateral and Regional Free Trade Agreements Affecting Domestic Intellectual Property Rules on Pharmaceuticals by Lisa Forman Chapter 5: Research Ethics 1. Human Genomic Research Ethics: Changing the Rules by Steven H. Miles 2. Assumptions in the Standard of Care Debate by Florencia Luna Chapter 6: Political Activism and Treatment Access 1. Medicines for All? Commitment and Compromise in the Fight for Canada's Law on Compulsory Licensing for Export by Richard Elliot 2. Placing Access to Essential Medicine on the Human Rights Agenda by Brook K. Baker Chapter 7: National Responsibilities 1. Producing Affordable Medicines in South Africa by Joao L. Carapinha 2. National Responsibility in the Provision of Basic Medicine by Kinsley Wilson, Laura Esmail and Jillian Clare Cohen 3. Pharmaceutical Cost-Effectiveness Pricing: Developing and Protecting a Global Ideal Form by Thomas A. Faunce Index
PortraitJillian Clare Cohen is an Assistant Professor at the Leslie Dan Faculty of Pharmacy, University of Toronto and Director of the Comparative Program on Health and Society. She conducts research and publishes widely on drug access including corruption and intellectual property rights. She has also advised governments and international organizations on pharmaceutical policy. Patricia Illingworth is an Associate Professor at Northeastern University. She has written three books, AIDS and the Good Society (1991), Trusting Medicine ( 2005), and Ethical Health Care (2006) with Wendy Parmet. Udo Schuklenk is a Professor of Ethics in Public Policy and Corporate Governance at Glasgow Caledonian University. He is a co-editor of the journal Bioethics and author of Access to Experimental Drugs in Terminal Illness: Ethical Issues (1998).
PressestimmenAn impressive collection of essays focusing on one of the most pressing issues of our time. The Power of Pills provides the resources for a debate we urgently need to have. -- Professor Peter Singer, Princeton University This concise, incisive book offers a comprehensive, timely review of ethical, legal, social, and trade concerns in pharmaceutical industry dynamics. No commentator on, or student or critic of, access to patented or generic drugs in affluent or impoverished markets, can claim to be relevantly informed without understanding the explanations and analyses these essays provide. -- Professor Bernard M. Dickens, University of Toronto
Untertitel: New. Sprache: Englisch.
Verlag: PLUTO PR
Erscheinungsdatum: Januar 2007
Seitenanzahl: 320 Seiten